Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MolMed SPA

www.molmed.com

Latest From MolMed SPA

Stem Cell Therapy Gets Boost With NICE Nod For Chiesi's Holoclar

Single treatment for one eye costs £80,000 but Chiesi is offering a discount for Europe's first approved stem cell medicinal product.

Regenerative Medicine Reimbursement

EMA, FDA Talk Real World Evidence, Mutual Recognition, Generic Drugs

US FDA and European Medicines Agency may expand sharing beyond manufacturing inspections to clinical trials and generic drug applications.

FDA Drug Approval Standards

Pulled From EU Assessment Process: Orphan Drugs For Kidney Disease, Mesothelioma

Two orphan medicines have been withdrawn from the evaluation process at the European Medicines Agency, one of them for recurrent nephrotic syndrome, the other for mesothelioma. Three products are undergoing a re-evaluation after an initial negative opinion from the CHMP.

Drug Review Europe

Finance Watch: Two More US Biopharma IPOs And Two New European VC Funds

Two biopharma IPOs in the US continue streak of (mostly) positive returns; two new European VC funds launch as Irish antibiotic developer raises $65m; and Halozyme, Ziopharm price offerings.

Business Strategies Commercial
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Italy
  • Parent & Subsidiaries
  • MolMed SPA
  • Senior Management
  • Claudio Bordignon, MD, Pres. & CEO
    Enrico Cappelli, CFO
    Gian Paolo, MD, Dir., Research
    Holger Neecke, PhD, Mgr., Bus. Dev.
  • Contact Info
  • MolMed SPA
    Phone: (39) 2 21277 1
    Via Olgettina 58
    Milan, 20132
    Italy
Advertisement
Advertisement
UsernamePublicRestriction

Register